These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures. French IT; Muthusamy KA Front Aging Neurosci; 2016; 8():114. PubMed ID: 27242523 [TBL] [Abstract][Full Text] [Related]
4. Fluphenazine (oral) versus placebo for schizophrenia. Matar HE; Almerie MQ; Sampson S Cochrane Database Syst Rev; 2013 Jul; 7(7):CD006352. PubMed ID: 23861067 [TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Pickar D; Labarca R; Linnoila M; Roy A; Hommer D; Everett D; Paul SM Science; 1984 Aug; 225(4665):954-7. PubMed ID: 6474162 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170 [TBL] [Abstract][Full Text] [Related]
7. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients. Konicki PE; Owen RR; Litman RE; Pickar D Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157 [TBL] [Abstract][Full Text] [Related]
8. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects. Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767 [TBL] [Abstract][Full Text] [Related]
9. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. Davidson M; Davis KL Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642 [TBL] [Abstract][Full Text] [Related]
10. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia. Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208 [TBL] [Abstract][Full Text] [Related]
11. Measurement of plasma homovanillic acid concentrations in schizophrenic patients. Kaminski R; Powchick P; Warne PA; Goldstein M; McQueeney RT; Davidson M Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):271-87. PubMed ID: 2193315 [TBL] [Abstract][Full Text] [Related]
12. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients. Pickar D; Breier A; Kelsoe J Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783 [TBL] [Abstract][Full Text] [Related]